Three-quarters of middle schools have vending machines where snacks and sugared drinks are sold, a new study finds.
The research demonstrates that there are vending machines in most middle schools, and "that those vending machines don't always have the healthiest choices," said study author Amy Virus, a registered dietitian with the Center for Obesity Research and Education at Temple University in Philadelphia.
The results come from a nationwide sample of 42 middle schools, and... read more
Submitted by Avera
TUESDAY, Nov. 18 (HealthDay News) -- Gleevec, a wonder drug that effectively treats leukemia and other cancers, may also reverse type 1 diabetes, University of California San Francisco, researchers report.
In experiments with mice, they found that Gleevec and a similar cancer drug, Sutent, could prevent the onset of type 1 diabetes. Type 1 diabetes is usually diagnosed in children and young adults, and is caused by the inability of the body to make insulin.
... read moreSubmitted by Avera
AMY-LEE NAKHL was the picture of health - but, in fact, she was at death's door. She ate healthily and drank lots and lots of water, just as the health experts advise.
However, it was her never-ending water guzzling that prompted a relative to suggest that perhaps something was wrong. Amy-Lee's mother, Belinda, took her to the doctor where alarms bells rang.
A quick blood-sugar test showed the then five-year-old's levels were at 38.5 -... read more
Submitted by Avera
NEW YORK (Reuters Health) - Patients with hepatocellular carcinoma (HCC) have a significantly higher prevalence of type 2 diabetes mellitus (DM) compared to the general population, according to findings from a case-control study conducted in Italy.
"The association of type (DM2) ... with hepatocellular carcinoma (HCC) has been long suspected," Dr. Valter Donadon, at Pordenone Hospital, and co-authors note in the October 7 issue of the World Journal of Gastroenterology. "However, the temporal relationship between... read more
Submitted by Avera
Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of proprietary drug delivery systems, presented the results of its exploratory study entitled "Enteral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs" at the Diabetes Technology Society's Conference in Bethesda, Maryland.
Oramed's drug delivery technology is being utilized for the oral delivery of polypeptides and proteins. The Company previously demonstrated that using its proprietary technology enables the delivery of insulin when administered orally.
Submitted by Avera
For years, doctors have actually known more about how to treat restless legs syndrome (RLS) than about what causes it. They've discovered that symptoms sometimes improve with medications that trigger the production of dopamine, a chemical in the brain that regulates movement and feelings of pleasure. But there is some evidence that dopamine is only one of many factors in causing RLS.
It's suspected that RLS acts up especially at night because dopamine levels follow... read more
Submitted by Avera
Excess weight is probably the number one risk factor for type 2 diabetes. Yes, other factors, such as genes and aging do play a role in type 2 diabetes.
But an International Obesity Task Force estimated in 2002 that 60% of diabetes cases around the world were due to weight gain, and in Western nations it was closer to 90%.
If you are obese or overweight, you are 90 times as likely to develop... read more
Submitted by Avera
THURSDAY, Nov. 13, 2008 (Health.com) — Peppermint oil, soluble fiber, and antispasmodic drugs can indeed help people with irritable bowel syndrome (IBS), according to an analysis of 25 years of research on the condition, which is characterized by bouts of diarrhea and constipation.
About 10% to 15% of people in North America have IBS, and it’s twice as common in women. However, only about one-third of people with the intestinal disorder seek treatment.
The exact... read more
Submitted by Avera
BETHESDA, Md., Nov. 14 /PRNewswire/ -- A new study presented today at the Annual Meeting of the Diabetes Technology Society showed that changes in the position of a conventional insulin pump, relative to its infusion set, can significantly impact expected insulin delivery rates. Such changes may occur during routine daily activities such as getting dressed, sleeping or showering. This siphon effect has been reported previously in hospital IV pumps, but this is the first time... read more
Submitted by Avera
Bhubaneswar (PTI): With diabetes taking alarming shape in India affecting at least 42 million of its people, a state-of-the-art medical facility is coming up here to deal with the problem.
"As India has been declared as diabetes capital of the world, a world class diabetes care facility is badly needed in the country," director of Cuttack Diabetes Research Foundation (CDRF), Dr Alok Kanungo, told reporters here.
Billed as the first of its kind... read more
Submitted by Avera